EXHIBIT 10.7 AGREEMENT OF LEASE DATED AS OF AUGUST 16, 1999 BY AND BETWEEN MERIDIAN CENTRE ASSOCIATES, L.P.Lease Agreement • June 26th, 2000 • Genencor International Inc • Services-commercial physical & biological research
RECITALSPledge Agreement • June 26th, 2000 • Genencor International Inc • Services-commercial physical & biological research • Delaware
WITNESSETH:Lease Agreement • March 26th, 2003 • Genencor International Inc • In vitro & in vivo diagnostic substances
ARTICLE I DEFINITIONSLicense Agreement • November 14th, 2001 • Genencor International Inc • In vitro & in vivo diagnostic substances • California
WITNESSETH:Lease • March 26th, 2003 • Genencor International Inc • In vitro & in vivo diagnostic substances
FORM OFIndemnification Agreement • July 24th, 2000 • Genencor International Inc • Services-commercial physical & biological research • Delaware
Rochester, New York Date: ___________, 2000Promissory Note • June 26th, 2000 • Genencor International Inc • Services-commercial physical & biological research
EXHIBIT 1.1 GENENCOR INTERNATIONAL, INC. (a Delaware corporation) 7,000,000 Shares of Common Stock PURCHASE AGREEMENT Dated: July [ ], 2000 TABLE OF CONTENTSPurchase Agreement • July 24th, 2000 • Genencor International Inc • Services-commercial physical & biological research • New York
AMENDMENT NO. 1Credit Agreement • May 23rd, 2001 • Genencor International Inc • In vitro & in vivo diagnostic substances • New York
RECITALSStockholder Agreement • March 12th, 2004 • Genencor International Inc • In vitro & in vivo diagnostic substances
EXHIBIT 10.1 FIRST AMENDMENT TO SUPPLY AGREEMENT ----------------------------------- This First Amendment to the Supply Agreement (the "Agreement") is made and entered into as of January 1, 2003 ("Effective Amendment Date") by and between The Procter...Supply Agreement • August 13th, 2003 • Genencor International Inc • In vitro & in vivo diagnostic substances
EPIMMUNE INC. SECURITIES PURCHASE AGREEMENT JULY 9, 2001Securities Purchase Agreement • November 14th, 2001 • Genencor International Inc • In vitro & in vivo diagnostic substances • California
EXHIBIT 10.20 EMPLOYMENT AGREEMENT THIS AGREEMENT made as of the date last written below by and between Genencor International, Inc. ("GCOR"), a Delaware Corporation with a principal office at 925 Page Mill Road, Palo Alto, California 94104-1013 and...Employment Agreement • March 26th, 2003 • Genencor International Inc • In vitro & in vivo diagnostic substances • California
LOGO] CHASE $16,000,000 364-Day CREDIT AGREEMENT dated as of January 31, 2001 amongCredit Agreement • May 23rd, 2001 • Genencor International Inc • In vitro & in vivo diagnostic substances • New York
EXHIBIT 4.9 GENENCOR INTERNATIONAL, INC. AMENDMENT NO. 5 TO NOTE AGREEMENTNote Agreement • March 26th, 2003 • Genencor International Inc • In vitro & in vivo diagnostic substances • New York
CONFIDENTIALLicense Agreement • July 27th, 2000 • Genencor International Inc • Services-commercial physical & biological research • Texas
AMENDMENT NO. 2Credit Agreement • March 29th, 2002 • Genencor International Inc • In vitro & in vivo diagnostic substances • New York
40,000,000 THREE YEARCredit Agreement • March 12th, 2004 • Genencor International Inc • In vitro & in vivo diagnostic substances • New York
LEASELease • June 26th, 2000 • Genencor International Inc • Services-commercial physical & biological research • New York
RECITALSRestricted Stock Purchase Agreement • June 26th, 2000 • Genencor International Inc • Services-commercial physical & biological research • Delaware
EXHIBIT 10.31 FIRST AMENDMENT OF THE COLLABORATION AGREEMENT This First Amendment (this "FIRST AMENDMENT") to the Collaboration Agreement is made and entered into as of October 16, 2002 by and between EPIMMUNE INC., having a principal place of...Collaboration Agreement • March 26th, 2003 • Genencor International Inc • In vitro & in vivo diagnostic substances
GENENCOR LOGO] MEMORANDUM DATE: 16 July, 1999 TO: Carl Copeland FROM: W. Thomas Mitchell RE: Employment Agreement CC: Richard J. Ranieri As you know we have evaluated the current organization as it relates to the future direction of the Company and...Employment Agreement • June 26th, 2000 • Genencor International Inc • Services-commercial physical & biological research
ARTICLE I DEFINITIONSTransfer Agreement • May 10th, 2004 • Genencor International Inc • In vitro & in vivo diagnostic substances • New York
ARTICLE I DEFINITIONSResearch Agreement • August 6th, 2004 • Genencor International Inc • In vitro & in vivo diagnostic substances • Delaware
EXHIBIT 10.2 EMPLOYMENT AND SEPARATION AGREEMENT This Employment and Separation Agreement (the "Agreement") is entered into by and between Stuart L. Melton ("Executive") and Genencor International, Inc. (the "Company" or"GCOR") effective as of the...Employment Agreement • August 6th, 2004 • Genencor International Inc • In vitro & in vivo diagnostic substances • California
December 17, 2002 [GENENCOR INTERNATIONAL LOGO] 925 Page Mill Road Palo Alto California 94304 Re: Letter Agreement 650.846.7500 650.845.6500 fax www.genencor.com Dear Debby Jo, For reasons we previously discussed, your employment with Genencor...Severance Agreement • March 26th, 2003 • Genencor International Inc • In vitro & in vivo diagnostic substances
1 EXHIBIT 10.12 TECHNOLOGY TRANSFER AGREEMENT This Agreement is effective June 30, 2000, between GENENCOR INTERNATIONAL, INC. (together with its Affiliates, "GCOR"), a Delaware corporation with offices at 200 Meridian Centre Boulevard, Rochester, New...Technology Transfer Agreement • July 27th, 2000 • Genencor International Inc • Services-commercial physical & biological research • Ohio
EXHIBIT 10.5 RENTAL AGREEMENT In accordance with chapter 5 of the Tenancy Act, dated April 29, 1966, the city of Hanko is hereby renting, to a corporation named Suomen Sokeri Osakeyhtio from the city of Helsinki, which below will be referred to as...Rental Agreement • August 6th, 2004 • Genencor International Inc • In vitro & in vivo diagnostic substances
EXHIBIT 10.3 EMPLOYMENT AGREEMENT THIS AGREEMENT made as of the date last written below by and between Genencor International, Inc. ("GCOR"), a Delaware Corporation with a principal office at 925 Page Mill Road, Palo Alto, California 94304-1013 and...Employment Agreement • August 6th, 2004 • Genencor International Inc • In vitro & in vivo diagnostic substances • California
COMMERCIALIZATION AGREEMENT BETWEEN THE PROCTER & GAMBLE COMPANY AND GENENCOR INTERNATIONAL, INC.Commercialization Agreement • July 27th, 2000 • Genencor International Inc • Services-commercial physical & biological research
Exhibit 10.10 FIFTH AMENDMENT TO COLLABORATIVE RESEARCH AND DEVELOPMENT AGREEMENT DATED 1ST SEPTEMBER, 1995 This Amendment (the "Fifth Amendment") dated 1 December 2001, is entered into by and between: E. I. du Pont de Nemours and Company, a...Collaborative Research and Development Agreement • March 29th, 2002 • Genencor International Inc • In vitro & in vivo diagnostic substances
RECITALSStockholder Agreement • March 26th, 2003 • Genencor International Inc • In vitro & in vivo diagnostic substances
EXHIBIT 4.7 GENENCOR INTERNATIONAL, INC. AMENDMENT NO. 3 TO NOTE AGREEMENTNote Agreement • March 26th, 2003 • Genencor International Inc • In vitro & in vivo diagnostic substances • New York
AMENDMENT NO. 2 TO NOTE AGREEMENTNote Agreement • March 26th, 2003 • Genencor International Inc • In vitro & in vivo diagnostic substances • New York
RECITALSStockholder Agreement • July 26th, 2000 • Genencor International Inc • Services-commercial physical & biological research • Delaware
